| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2000 | EP0821730A4 Chimeric receptors for regulating cellular proliferation and effector function |
| 04/19/2000 | EP0789711B1 Identification of the p21-waf1 -pcna interaction site and therapeutic applications thereof |
| 04/19/2000 | EP0667872B1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 04/19/2000 | EP0644893B1 Inhibition of trauma-induced tumor growth |
| 04/19/2000 | EP0598840B1 Human calcium channel compositions and methods |
| 04/19/2000 | EP0567528B1 Depot formulations |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251047A Process for stimulating neural regeneration |
| 04/19/2000 | CN1251043A Use of protein extractable from animal organs for prepn. of medicaments for treatment of pathological conditions |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/19/2000 | CN1251041A Fine tuned progegrins |
| 04/19/2000 | CN1250780A Shark liver irritant for preventing and curing hepatism and its preparing process |
| 04/19/2000 | CN1250669A Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 04/19/2000 | CN1250668A Stable protein compositions |
| 04/19/2000 | CN1250667A Process for preparing genetically engineered polypeptide medicine with Chinese-medicinal materials as main raw material |
| 04/19/2000 | CN1051456C Process for preparing nerve growth factor |
| 04/18/2000 | US6051754 Nucleic acid construct including a nucleotide sequence encoding a polypeptide which desaturates a fatty acid at carbon 5 from the carboxyl end and operably associated with regulatory sequences for gene expression in plants |
| 04/18/2000 | US6051705 Having inhibitory activity against angiotensin i converting enzyme and neutral endpeptidase |
| 04/18/2000 | US6051698 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |
| 04/18/2000 | US6051694 Mixing solid protein and a critical fluid in which the protein is insoluble, then rapid depressurization of mixture; product is active but solvent/salt/surfactant-free; for time-released drug delivery |
| 04/18/2000 | US6051692 Amino acid sequence; for prevention, treatment and diagnosis of disorders associated with cellular development and differentiation and retinoid metabolism; vision defects; skin disorders; urogenital disorders; addison's disease |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051690 NSP molecules |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051684 Contacting a composition containing amyloid precursor protein with di- or tripeptide analog causing a decrease in a-beta-peptide or an increase in alpha-s-amyloid precursor protein |
| 04/18/2000 | US6051683 Immune regulating peptides and method of obtaining them |
| 04/18/2000 | US6051596 Immunosuppressive compositions |
| 04/18/2000 | US6051588 Which have significantly reduced gastrointestinal side effects |
| 04/18/2000 | US6051568 Thrombin inhibitors, their preparation and use |
| 04/18/2000 | US6051561 Compounds and compositions for delivering active agents |
| 04/18/2000 | US6051559 Cloning and characterizing of genes associated with long-term memory |
| 04/18/2000 | US6051558 Compositions suitable for controlled release of the hormone GnRH and its analogs |
| 04/18/2000 | US6051557 Methods of enhancing functioning of the upper gastrointestinal tract |
| 04/18/2000 | US6051555 Administering a peptide |
| 04/18/2000 | US6051553 Method for potentiating BPI protein product bactericidal activity by administration of LBP protein products |
| 04/18/2000 | US6051552 Biosurfactant; prevent urogenital infections |
| 04/18/2000 | US6051551 Antidiabetic agents; hypoglycemic agents; inhalationadministering |
| 04/18/2000 | US6051549 Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof |
| 04/18/2000 | US6051428 Transducing tumor cells with herpes simplex virus amplicon containing gene coding for cytokines, chemokines, cellular adhesion molecules, or costimulatory molecules which activate b or t-cells for transient expression of the protein |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051415 Methods and kits for stimulating production of megakaryocytes and thrombocytes |
| 04/18/2000 | US6051413 Valyl tRNA synthetase from Streptococcus pneumoniae |
| 04/18/2000 | US6051412 Glycyl tRNA synthetase from streptococcus pneumoniae |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051405 An expression vector containing a dna segment that directs the synthesis of a recombinant fusion protein which is a single chain fab variable region from a modified pseudomonas exotoxin gene; producing improved toxins |
| 04/18/2000 | US6051403 A dna molecule encoding a polypeptide having homology to sh2 domains as determined by blast-2 sequence alignment computer program; modulating intracellular signaling pathways |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051398 Nucleic acids encoding CR3 polypeptide, vector and transformed cell thereof, and expression thereof |
| 04/18/2000 | US6051397 DNA encoding MCK-10, a novel receptor tyrosine kinase |
| 04/18/2000 | US6051396 Method for producing retinoblastoma gene protein products |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051260 Parboiled rice flour is used in lieu of other grain flour |
| 04/18/2000 | US6051259 Composition for sustained release of human growth hormone |
| 04/18/2000 | US6051256 Dispersible macromolecule compositions and methods for their preparation and use |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051231 Antiviral methods and prepations |
| 04/18/2000 | US6051230 For treatment and/or diagnosis (imaging) of vascularized solid tumors |
| 04/18/2000 | US6051228 Antibodies against human CD40 |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051225 Family of high affinity, modified antibodies for cancer treatment |
| 04/18/2000 | US6051224 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion |
| 04/18/2000 | US6051223 Mixing with anionic polymer, acid, amine or their salts |
| 04/18/2000 | US6051222 Cancer diagnosis; genetic engineering |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051220 Composition to improve digestibility and utilization of nutrients |
| 04/18/2000 | US6051218 Administering cell expressing interleukin-3 |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | CA2092195C Retroviral packaging cell line |
| 04/18/2000 | CA2071956C Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
| 04/18/2000 | CA2019005C Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain |
| 04/18/2000 | CA1340964C Crf analogs |
| 04/18/2000 | CA1340963C Gene for encoding a human malaria vaccine antigen |
| 04/15/2000 | CA2284853A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 04/13/2000 | WO2000020867A1 A novel ret-independent signaling pathway for gdnf |
| 04/13/2000 | WO2000020645A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF TUMOR NECROSIS FACTOR-α (TNF-α) EXPRESSION |
| 04/13/2000 | WO2000020638A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | WO2000020635A1 ANTISENSE MODULATION OF INTEGRIN α4 EXPRESSION |
| 04/13/2000 | WO2000020627A1 Use of ynes, essential bacterial genes and polypeptides |
| 04/13/2000 | WO2000020625A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020619A2 Secreted renilla luciferase |
| 04/13/2000 | WO2000020612A2 Therapeutically active proteins in plants |
| 04/13/2000 | WO2000020607A2 Chimaeric proteins between members of tgf-beta superfamily |
| 04/13/2000 | WO2000020606A1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
| 04/13/2000 | WO2000020604A2 Oxidoreductase molecules |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020595A1 Interleukin-1 homolog |
| 04/13/2000 | WO2000020594A1 Tsg-5: a tnf-inducible gene |
| 04/13/2000 | WO2000020593A1 Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
| 04/13/2000 | WO2000020592A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020589A2 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |